MHRP researchers and collaborators will give the following presentations at the 66th Annual ASTMH Meeting taking place November 5-9 in Baltimore:
Tuesday, November 7
Safety/Immunogenicity of a Single Intramuscular Dose of the Investigational Recombinant Chimpanzee Adenovirus Type 3-Vectored Ebola Zaire Vaccine (ChAd3-EBO-Z) in Children in Africa: A Phase 2, Randomized, Controlled Study*
--Milagritos Tapia (MHRP Collaborator), Session 67, 8:00 a.m.
Patterns of HIV status Disclosure to Household Members in an African Cohort
--Akindiran Akintunde (MHRP Collaborator), Session 86, 12:00 p.m.
Rates of Tuberculosis Diagnosis Among an HIV-Positive Cohort in 4 African Countries
--Kavitha Ganesan (MHRP), Session 86, 12:00 p.m.
Longitudinal Assessment of CD4 Recovery after ART Initiation in ART-naïve HIV-infected Adults in Four African Countries
--Emmanuel Bahemana (MHRP Collaborator), Session 86, 12:00 p.m.
Prospective Value of Quantiferon TB Gold for Active Tuberculosis in ART Naive HIV Positive Individuals in the African Cohort Study
--Inge Kroidl (MHRP Collaborator), Session 86, 12:00 p.m.
Wednesday, November 8
Deployment and Travel Health: Knowledge, Attitudes, Practice and Outcomes Study (KAPOS)*
--Patrick Hickey (MHRP), Session 122, 9:00 a.m.
Demographic and Contextual Factors Associated with HIV Mortality in an African Cohort in East Africa and Nigeria*
--Hannah Kibuuka (MHRP Collaborator), Session 143, 10:15 a.m.
Rate of Viremia and its Preditors Among Adult HIV-infected Patients in the African HIV Cohort Study*
--Francis Kiweewa (MHRP Collaborator), Session 143, 10:15 a.m.
Cryptococcal Antigenemia in HIV-infected Adults in the African Cohort Study*
--Valentine Sing-oei (MHRP Collaborator), Session 143, 10:15 a.m.
Thursday, November 9
JWARG Symposium: Preparing for the Next Epidemic through Military and Civilian Partnerships in West Africa
Session 196, 11:15 a.m.
The West African Ebola outbreak in 2014-2015 highlighted gaps in the global public health response and a lack of countermeasures. To help address this, the U.S. Department of Defense (DoD) invested in a strategic initiative called the Joint West Africa Research Group (JWARG) to leverage existing research platforms and relationships to improve bio-preparedness in the region.
This symposium aims to highlight the unique role JWARG plays in capacity building and health system strengthening in the West African sub-region. The session is centered around perspectives of West African scientists and features early career investigators.
The first panel will highlight capacity-building activities through partnerships. Speakers from the U.S., Nigeria, Ghana and Liberia will describe efforts to improve diagnostics and clinical surveillance of infectious disease leveraging the network. From building wells for clean water supply to getting a microbiology lab running and completing the first blood culture in Liberia for several years, speakers will highlight challenges faced.
The second panel will introduce the research agenda around emerging infectious diseases through collaborative efforts among partner laboratory and research organizations. Speakers will discuss efforts around site and protocol development to begin surveillance studies and vaccine trials. The regulatory and ethical framework around research studies in this setting will be addressed.